Behavioral and neuroendocrine responses to m-chlorophenylpiperazine in subtypes of alcoholics and in healthy comparison subjects
OBJECTIVE: The purpose of this study was to explore central serotonergic functions in subgroups of alcoholics and in healthy comparison subjects. METHOD: The mixed serotonin (5-HT) agonist/antagonist m-chlorophenylpiperazine (m-CPP) was administered to male alcoholic patients who were classified acc...
Gespeichert in:
Veröffentlicht in: | The American journal of psychiatry 1997-01, Vol.154 (1), p.81-87 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | OBJECTIVE: The purpose of this study was to explore central serotonergic
functions in subgroups of alcoholics and in healthy comparison subjects.
METHOD: The mixed serotonin (5-HT) agonist/antagonist
m-chlorophenylpiperazine (m-CPP) was administered to male alcoholic
patients who were classified according to the criteria of von Knorring et
al. as type I alcoholics (late onset) (N = 16) or type II alcoholics (early
onset with antisocial traits) (N = 24) and to 22 healthy comparison
subjects. Psychological, physiological, and neuroendocrine measures were
obtained before and after the m-CPP infusion. RESULTS: m-CPP elicited
subtype-related differential effects among the alcoholics; the type I
alcoholics reported more anger and anxiety, and the type II alcoholics
reported increased euphoria and a greater likelihood of drinking. The
healthy comparison subjects exhibited a greater increase in plasma ACTH
response to the m-CPP infusion than the alcoholics regardless of subtype.
CONCLUSIONS: Differences in certain 5-HT receptor functions may explain
some of the clinical characteristics that differentiate the type II and
type I subgroups of alcoholic patients. Furthermore, alcoholics may have
reduced sensitivity of 5-HT2C receptors in comparison with healthy
subjects. |
---|---|
ISSN: | 0002-953X 1535-7228 |
DOI: | 10.1176/ajp.154.1.81 |